EquitySector - HealthcareVery High Risk
NAV (25-Apr-25)
Returns (Since Inception)
Fund Size
₹28 Cr
Expense Ratio
0.22%
ISIN
INF247L01BB1
Minimum SIP
-
Exit Load
-
Inception Date
29 Jul 2022
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+19.02%
+21.42% (Cat Avg.)
Since Inception
+25.07%
— (Cat Avg.)
Equity | ₹27.73 Cr | 99.88% |
Others | ₹0.03 Cr | 0.12% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | ₹4.19 Cr | 15.10% |
Cipla Ltd | Equity | ₹1.82 Cr | 6.57% |
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹1.81 Cr | 6.53% |
Divi's Laboratories Ltd | Equity | ₹1.65 Cr | 5.93% |
Dr Reddy's Laboratories Ltd | Equity | ₹1.56 Cr | 5.62% |
Apollo Hospitals Enterprise Ltd | Equity | ₹1.49 Cr | 5.37% |
Lupin Ltd | Equity | ₹1.1 Cr | 3.95% |
Fortis Healthcare Ltd | Equity | ₹0.81 Cr | 2.93% |
Torrent Pharmaceuticals Ltd | Equity | ₹0.76 Cr | 2.73% |
Aurobindo Pharma Ltd | Equity | ₹0.72 Cr | 2.60% |
Mankind Pharma Ltd | Equity | ₹0.6 Cr | 2.17% |
Alkem Laboratories Ltd | Equity | ₹0.57 Cr | 2.07% |
Laurus Labs Ltd | Equity | ₹0.53 Cr | 1.92% |
Glenmark Pharmaceuticals Ltd | Equity | ₹0.52 Cr | 1.86% |
Zydus Lifesciences Ltd | Equity | ₹0.5 Cr | 1.80% |
Ipca Laboratories Ltd | Equity | ₹0.47 Cr | 1.69% |
Abbott India Ltd | Equity | ₹0.35 Cr | 1.26% |
Krishna Institute of Medical Sciences Ltd | Equity | ₹0.35 Cr | 1.26% |
Biocon Ltd | Equity | ₹0.34 Cr | 1.22% |
Suven Pharmaceuticals Ltd | Equity | ₹0.33 Cr | 1.19% |
Syngene International Ltd | Equity | ₹0.31 Cr | 1.11% |
Piramal Pharma Ltd | Equity | ₹0.31 Cr | 1.10% |
Gland Pharma Ltd | Equity | ₹0.28 Cr | 1.01% |
Wockhardt Ltd | Equity | ₹0.26 Cr | 0.95% |
GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹0.26 Cr | 0.94% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹0.26 Cr | 0.94% |
Narayana Hrudayalaya Ltd | Equity | ₹0.26 Cr | 0.92% |
Ajanta Pharma Ltd | Equity | ₹0.25 Cr | 0.90% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹0.24 Cr | 0.88% |
Neuland Laboratories Limited | Equity | ₹0.23 Cr | 0.84% |
Global Health Ltd | Equity | ₹0.22 Cr | 0.80% |
Concord Biotech Ltd | Equity | ₹0.22 Cr | 0.79% |
Dr. Lal PathLabs Ltd | Equity | ₹0.2 Cr | 0.73% |
Poly Medicure Ltd | Equity | ₹0.19 Cr | 0.70% |
Natco Pharma Ltd | Equity | ₹0.16 Cr | 0.58% |
Rainbow Childrens Medicare Ltd | Equity | ₹0.16 Cr | 0.57% |
Granules India Ltd | Equity | ₹0.16 Cr | 0.57% |
Jubilant Pharmova Ltd | Equity | ₹0.15 Cr | 0.55% |
Pfizer Ltd | Equity | ₹0.14 Cr | 0.49% |
Ami Organics Ltd | Equity | ₹0.13 Cr | 0.48% |
Eris Lifesciences Ltd Registered Shs | Equity | ₹0.13 Cr | 0.48% |
Jupiter Life Line Hospitals Ltd | Equity | ₹0.13 Cr | 0.48% |
AstraZeneca Pharma India Ltd | Equity | ₹0.12 Cr | 0.43% |
Sanofi India Ltd | Equity | ₹0.12 Cr | 0.41% |
Alembic Pharmaceuticals Ltd | Equity | ₹0.11 Cr | 0.41% |
Vijaya Diagnostic Centre Ltd | Equity | ₹0.11 Cr | 0.38% |
Marksans Pharma Ltd | Equity | ₹0.1 Cr | 0.37% |
Strides Pharma Science Ltd | Equity | ₹0.1 Cr | 0.36% |
Indegene Ltd | Equity | ₹0.1 Cr | 0.36% |
Sanofi Consumer Healthcare India Ltd | Equity | ₹0.1 Cr | 0.35% |
Caplin Point Laboratories Ltd | Equity | ₹0.09 Cr | 0.33% |
Procter & Gamble Health Ltd | Equity | ₹0.09 Cr | 0.33% |
Metropolis Healthcare Ltd | Equity | ₹0.09 Cr | 0.33% |
Aarti Pharmalabs Ltd | Equity | ₹0.08 Cr | 0.30% |
Sai Life Sciences Ltd | Equity | ₹0.08 Cr | 0.29% |
Shilpa Medicare Ltd | Equity | ₹0.08 Cr | 0.29% |
Alivus Life Sciences Ltd | Equity | ₹0.07 Cr | 0.27% |
Kovai Medical Center & Hospital Ltd | Equity | ₹0.05 Cr | 0.19% |
HealthCare Global Enterprises Ltd | Equity | ₹0.05 Cr | 0.18% |
Blue Jet Healthcare Ltd | Equity | ₹0.05 Cr | 0.17% |
Emcure Pharmaceuticals Ltd | Equity | ₹0.05 Cr | 0.16% |
FDC Ltd | Equity | ₹0.04 Cr | 0.16% |
Supriya Lifescience Ltd | Equity | ₹0.04 Cr | 0.15% |
Indraprastha Medical Corp Ltd | Equity | ₹0.04 Cr | 0.14% |
Morepen Laboratories Ltd | Equity | ₹0.04 Cr | 0.14% |
Yatharth Hospital and Trauma Care Services Ltd | Equity | ₹0.04 Cr | 0.13% |
Solara Active Pharma Sciences Ltd Ordinary Shares | Equity | ₹0.03 Cr | 0.13% |
Net Receivables / (Payables) | Cash | ₹0.03 Cr | 0.12% |
Sequent Scientific Ltd | Equity | ₹0.03 Cr | 0.12% |
Hikal Ltd | Equity | ₹0.03 Cr | 0.12% |
Sun Pharma Advanced Research Co Ltd | Equity | ₹0.03 Cr | 0.12% |
Krsnaa Diagnostics Ltd | Equity | ₹0.03 Cr | 0.11% |
Unichem Laboratories Ltd | Equity | ₹0.03 Cr | 0.11% |
Dishman Carbogen Amics Ltd | Equity | ₹0.03 Cr | 0.11% |
Innova Captab Ltd | Equity | ₹0.03 Cr | 0.11% |
Advanced Enzyme Technologies Ltd | Equity | ₹0.03 Cr | 0.11% |
Akums Drugs and Pharmaceuticals Ltd | Equity | ₹0.03 Cr | 0.10% |
Aarti Drugs Ltd | Equity | ₹0.03 Cr | 0.10% |
Orchid Pharma Ltd | Equity | ₹0.03 Cr | 0.10% |
Thyrocare Technologies Ltd | Equity | ₹0.02 Cr | 0.08% |
RPG Life Sciences Ltd | Equity | ₹0.02 Cr | 0.08% |
Gufic Biosciences Ltd | Equity | ₹0.02 Cr | 0.07% |
Gujarat Themis Biosyn Ltd | Equity | ₹0.02 Cr | 0.07% |
Indoco Remedies Ltd | Equity | ₹0.02 Cr | 0.07% |
Windlas Biotech Ltd | Equity | ₹0.02 Cr | 0.07% |
Artemis Medicare Services Ltd Ordinary Shares | Equity | ₹0.02 Cr | 0.06% |
Bliss GVS Pharma Ltd | Equity | ₹0.02 Cr | 0.06% |
Syncom Formulation (India) Ltd | Equity | ₹0.02 Cr | 0.06% |
Vimta Labs Ltd | Equity | ₹0.02 Cr | 0.06% |
Suven Life Sciences Ltd | Equity | ₹0.02 Cr | 0.06% |
IOL Chemicals And Pharmaceuticals Ltd | Equity | ₹0.02 Cr | 0.06% |
Sigachi Industries Ltd | Equity | ₹0.01 Cr | 0.05% |
SMS Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.05% |
Shalby Ltd | Equity | ₹0.01 Cr | 0.04% |
Lincoln Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.04% |
Novartis India Ltd | Equity | ₹0.01 Cr | 0.04% |
Hester Biosciences Ltd | Equity | ₹0.01 Cr | 0.04% |
Kopran Ltd | Equity | ₹0.01 Cr | 0.04% |
Tarsons Products Ltd | Equity | ₹0.01 Cr | 0.04% |
Senores Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.04% |
Themis Medicare Ltd | Equity | ₹0.01 Cr | 0.03% |
GPT Healthcare Ltd | Equity | ₹0.01 Cr | 0.03% |
Suraksha Diagnostic Ltd | Equity | ₹0.01 Cr | 0.03% |
KMC Speciality Hospitals (India) Ltd | Equity | ₹0.01 Cr | 0.02% |
Sastasundar Ventures Ltd | Equity | ₹0 Cr | 0.02% |
NGL Fine-Chem Ltd | Equity | ₹0 Cr | 0.02% |
Large Cap Stocks
37.74%
Mid Cap Stocks
34.60%
Small Cap Stocks
26.70%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹27.34 Cr | 98.45% |
Basic Materials | ₹0.16 Cr | 0.59% |
Standard Deviation
This fund
--
Cat. avg.
16.77%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.75
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.30
Higher the better
ISIN INF247L01BB1 | Expense Ratio 0.22% | Exit Load - | Fund Size ₹28 Cr | Age 2 years 8 months | Lumpsum Minimum ₹500 | Fund Status Open Ended Investment Company | Benchmark BSE Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹82,928 Cr
Address
Motilal Oswal Tower, Mumbai, 400 025
Your principal amount will be at Very High Risk
EquitySector - HealthcareVery High Risk
NAV (25-Apr-25)
Returns (Since Inception)
Fund Size
₹28 Cr
Expense Ratio
0.22%
ISIN
INF247L01BB1
Minimum SIP
-
Exit Load
-
Inception Date
29 Jul 2022
Your principal amount will be at Very High Risk
In this section, we compare the returns of the scheme with the category average over various periods. Periods for which the fund has outperformed its category average are marked in green, otherwise red.
1 Year
+19.02%
+21.42% (Cat Avg.)
Since Inception
+25.07%
— (Cat Avg.)
Equity | ₹27.73 Cr | 99.88% |
Others | ₹0.03 Cr | 0.12% |
All Holdings
Equity
Debt & Others
Name | Type | Amount | Holdings |
---|---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | ₹4.19 Cr | 15.10% |
Cipla Ltd | Equity | ₹1.82 Cr | 6.57% |
Max Healthcare Institute Ltd Ordinary Shares | Equity | ₹1.81 Cr | 6.53% |
Divi's Laboratories Ltd | Equity | ₹1.65 Cr | 5.93% |
Dr Reddy's Laboratories Ltd | Equity | ₹1.56 Cr | 5.62% |
Apollo Hospitals Enterprise Ltd | Equity | ₹1.49 Cr | 5.37% |
Lupin Ltd | Equity | ₹1.1 Cr | 3.95% |
Fortis Healthcare Ltd | Equity | ₹0.81 Cr | 2.93% |
Torrent Pharmaceuticals Ltd | Equity | ₹0.76 Cr | 2.73% |
Aurobindo Pharma Ltd | Equity | ₹0.72 Cr | 2.60% |
Mankind Pharma Ltd | Equity | ₹0.6 Cr | 2.17% |
Alkem Laboratories Ltd | Equity | ₹0.57 Cr | 2.07% |
Laurus Labs Ltd | Equity | ₹0.53 Cr | 1.92% |
Glenmark Pharmaceuticals Ltd | Equity | ₹0.52 Cr | 1.86% |
Zydus Lifesciences Ltd | Equity | ₹0.5 Cr | 1.80% |
Ipca Laboratories Ltd | Equity | ₹0.47 Cr | 1.69% |
Abbott India Ltd | Equity | ₹0.35 Cr | 1.26% |
Krishna Institute of Medical Sciences Ltd | Equity | ₹0.35 Cr | 1.26% |
Biocon Ltd | Equity | ₹0.34 Cr | 1.22% |
Suven Pharmaceuticals Ltd | Equity | ₹0.33 Cr | 1.19% |
Syngene International Ltd | Equity | ₹0.31 Cr | 1.11% |
Piramal Pharma Ltd | Equity | ₹0.31 Cr | 1.10% |
Gland Pharma Ltd | Equity | ₹0.28 Cr | 1.01% |
Wockhardt Ltd | Equity | ₹0.26 Cr | 0.95% |
GlaxoSmithKline Pharmaceuticals Ltd | Equity | ₹0.26 Cr | 0.94% |
J.B. Chemicals & Pharmaceuticals Ltd | Equity | ₹0.26 Cr | 0.94% |
Narayana Hrudayalaya Ltd | Equity | ₹0.26 Cr | 0.92% |
Ajanta Pharma Ltd | Equity | ₹0.25 Cr | 0.90% |
Aster DM Healthcare Ltd Ordinary Shares | Equity | ₹0.24 Cr | 0.88% |
Neuland Laboratories Limited | Equity | ₹0.23 Cr | 0.84% |
Global Health Ltd | Equity | ₹0.22 Cr | 0.80% |
Concord Biotech Ltd | Equity | ₹0.22 Cr | 0.79% |
Dr. Lal PathLabs Ltd | Equity | ₹0.2 Cr | 0.73% |
Poly Medicure Ltd | Equity | ₹0.19 Cr | 0.70% |
Natco Pharma Ltd | Equity | ₹0.16 Cr | 0.58% |
Rainbow Childrens Medicare Ltd | Equity | ₹0.16 Cr | 0.57% |
Granules India Ltd | Equity | ₹0.16 Cr | 0.57% |
Jubilant Pharmova Ltd | Equity | ₹0.15 Cr | 0.55% |
Pfizer Ltd | Equity | ₹0.14 Cr | 0.49% |
Ami Organics Ltd | Equity | ₹0.13 Cr | 0.48% |
Eris Lifesciences Ltd Registered Shs | Equity | ₹0.13 Cr | 0.48% |
Jupiter Life Line Hospitals Ltd | Equity | ₹0.13 Cr | 0.48% |
AstraZeneca Pharma India Ltd | Equity | ₹0.12 Cr | 0.43% |
Sanofi India Ltd | Equity | ₹0.12 Cr | 0.41% |
Alembic Pharmaceuticals Ltd | Equity | ₹0.11 Cr | 0.41% |
Vijaya Diagnostic Centre Ltd | Equity | ₹0.11 Cr | 0.38% |
Marksans Pharma Ltd | Equity | ₹0.1 Cr | 0.37% |
Strides Pharma Science Ltd | Equity | ₹0.1 Cr | 0.36% |
Indegene Ltd | Equity | ₹0.1 Cr | 0.36% |
Sanofi Consumer Healthcare India Ltd | Equity | ₹0.1 Cr | 0.35% |
Caplin Point Laboratories Ltd | Equity | ₹0.09 Cr | 0.33% |
Procter & Gamble Health Ltd | Equity | ₹0.09 Cr | 0.33% |
Metropolis Healthcare Ltd | Equity | ₹0.09 Cr | 0.33% |
Aarti Pharmalabs Ltd | Equity | ₹0.08 Cr | 0.30% |
Sai Life Sciences Ltd | Equity | ₹0.08 Cr | 0.29% |
Shilpa Medicare Ltd | Equity | ₹0.08 Cr | 0.29% |
Alivus Life Sciences Ltd | Equity | ₹0.07 Cr | 0.27% |
Kovai Medical Center & Hospital Ltd | Equity | ₹0.05 Cr | 0.19% |
HealthCare Global Enterprises Ltd | Equity | ₹0.05 Cr | 0.18% |
Blue Jet Healthcare Ltd | Equity | ₹0.05 Cr | 0.17% |
Emcure Pharmaceuticals Ltd | Equity | ₹0.05 Cr | 0.16% |
FDC Ltd | Equity | ₹0.04 Cr | 0.16% |
Supriya Lifescience Ltd | Equity | ₹0.04 Cr | 0.15% |
Indraprastha Medical Corp Ltd | Equity | ₹0.04 Cr | 0.14% |
Morepen Laboratories Ltd | Equity | ₹0.04 Cr | 0.14% |
Yatharth Hospital and Trauma Care Services Ltd | Equity | ₹0.04 Cr | 0.13% |
Solara Active Pharma Sciences Ltd Ordinary Shares | Equity | ₹0.03 Cr | 0.13% |
Net Receivables / (Payables) | Cash | ₹0.03 Cr | 0.12% |
Sequent Scientific Ltd | Equity | ₹0.03 Cr | 0.12% |
Hikal Ltd | Equity | ₹0.03 Cr | 0.12% |
Sun Pharma Advanced Research Co Ltd | Equity | ₹0.03 Cr | 0.12% |
Krsnaa Diagnostics Ltd | Equity | ₹0.03 Cr | 0.11% |
Unichem Laboratories Ltd | Equity | ₹0.03 Cr | 0.11% |
Dishman Carbogen Amics Ltd | Equity | ₹0.03 Cr | 0.11% |
Innova Captab Ltd | Equity | ₹0.03 Cr | 0.11% |
Advanced Enzyme Technologies Ltd | Equity | ₹0.03 Cr | 0.11% |
Akums Drugs and Pharmaceuticals Ltd | Equity | ₹0.03 Cr | 0.10% |
Aarti Drugs Ltd | Equity | ₹0.03 Cr | 0.10% |
Orchid Pharma Ltd | Equity | ₹0.03 Cr | 0.10% |
Thyrocare Technologies Ltd | Equity | ₹0.02 Cr | 0.08% |
RPG Life Sciences Ltd | Equity | ₹0.02 Cr | 0.08% |
Gufic Biosciences Ltd | Equity | ₹0.02 Cr | 0.07% |
Gujarat Themis Biosyn Ltd | Equity | ₹0.02 Cr | 0.07% |
Indoco Remedies Ltd | Equity | ₹0.02 Cr | 0.07% |
Windlas Biotech Ltd | Equity | ₹0.02 Cr | 0.07% |
Artemis Medicare Services Ltd Ordinary Shares | Equity | ₹0.02 Cr | 0.06% |
Bliss GVS Pharma Ltd | Equity | ₹0.02 Cr | 0.06% |
Syncom Formulation (India) Ltd | Equity | ₹0.02 Cr | 0.06% |
Vimta Labs Ltd | Equity | ₹0.02 Cr | 0.06% |
Suven Life Sciences Ltd | Equity | ₹0.02 Cr | 0.06% |
IOL Chemicals And Pharmaceuticals Ltd | Equity | ₹0.02 Cr | 0.06% |
Sigachi Industries Ltd | Equity | ₹0.01 Cr | 0.05% |
SMS Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.05% |
Shalby Ltd | Equity | ₹0.01 Cr | 0.04% |
Lincoln Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.04% |
Novartis India Ltd | Equity | ₹0.01 Cr | 0.04% |
Hester Biosciences Ltd | Equity | ₹0.01 Cr | 0.04% |
Kopran Ltd | Equity | ₹0.01 Cr | 0.04% |
Tarsons Products Ltd | Equity | ₹0.01 Cr | 0.04% |
Senores Pharmaceuticals Ltd | Equity | ₹0.01 Cr | 0.04% |
Themis Medicare Ltd | Equity | ₹0.01 Cr | 0.03% |
GPT Healthcare Ltd | Equity | ₹0.01 Cr | 0.03% |
Suraksha Diagnostic Ltd | Equity | ₹0.01 Cr | 0.03% |
KMC Speciality Hospitals (India) Ltd | Equity | ₹0.01 Cr | 0.02% |
Sastasundar Ventures Ltd | Equity | ₹0 Cr | 0.02% |
NGL Fine-Chem Ltd | Equity | ₹0 Cr | 0.02% |
Large Cap Stocks
37.74%
Mid Cap Stocks
34.60%
Small Cap Stocks
26.70%
Equity Sector
Debt & Others
Sector | Amount | Holdings |
---|---|---|
Healthcare | ₹27.34 Cr | 98.45% |
Basic Materials | ₹0.16 Cr | 0.59% |
Standard Deviation
This fund
--
Cat. avg.
16.77%
Lower the better
Sharpe Ratio
This fund
--
Cat. avg.
0.75
Higher the better
Sortino Ratio
This fund
--
Cat. avg.
1.30
Higher the better
ISIN INF247L01BB1 | Expense Ratio 0.22% | Exit Load - | Fund Size ₹28 Cr | Age 2 years 8 months | Lumpsum Minimum ₹500 | Fund Status Open Ended Investment Company | Benchmark BSE Healthcare TR INR |
To seek to generate long-term capital growth from an actively managed portfolio primarily of Equity and Equity Related Securities. Scheme shall invest in Indian equities,foreign equities and related instruments and debt securities.
Note: As per the Income Tax Budget 2024, mutual funds are subject to capital gains taxation, which includes surcharge and cess based on prevailing income tax rules and the investor’s income. Taxation applies only to realised gains, not notional gains. Please consult your tax advisors to determine the implications or consequences of your investments in such securities.
Total AUM
₹82,928 Cr
Address
Motilal Oswal Tower, Mumbai, 400 025
Get your portfolio reviewed by experts
Download Wealth Monitor App
Track and monitor all
your investments